Cesca Therapeutics Inc (KOOL.OQ)
21 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|45||2017||Chairman of the Board, President, Chief Executive Officer|
|2017||Principal Financial Officer, Principal Accounting Officer|
|40||Executive Director of India Operations, Director of Clinical and Scientific Affairs|
|2017||Chief Operating Officer|
|49||2016||Vice President of Manufacturing and Global Supply Chain|
- BRIEF-Cesca Prices $5.5 Million Public Offering
- BRIEF-Cesca Therapeutics Reports Q1 Loss Per Share $0.27
- BRIEF-Cesca Therapeutics Says Offering Up To 3.2 Million Units
- BRIEF-Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina For X-Series Products
- BRIEF-Cesca Therapeutics Entered Amendment To Revolving Line Of Credit Facility